Zobrazeno 1 - 10
of 286
pro vyhledávání: '"Canatan D"'
Background: Data on the prevalence and type of endocrine disorders in β-thalassemia intermedia (β-TI) patients are scarce. This multicenter study was designed to determine the prevalence of endocrine complications and the associated risk factors in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::84a01e57a24fec7463df58e1e55d2eae
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078628
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078628
A review of the literature on COVID-19 pandemic in patients with thalassemias is presented. Globally, the prevalence of COVID-19 among β-thalassemia patients seems to be lower than in general population; associated co-morbidities aggravated the seve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::873f86de0fe2d1013f35746b3f21149a
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3120729
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3120729
Background: More than five decades ago, thalassemia major (TDT) was fatal in the first decade of life. Survival and quality of life have improved progressively thanks to the implementation of a significant advance in diagnostic and therapeutic method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::2ebb147fe7f1ce452b0304f114f58418
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3121897
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3121897
Background: Transfusion-dependent β-thalassemia (TDT) is associated with several complications necessitating a multidisciplinary approach for diagnosis, treatment and follow-up. Hypogonadism in female TDT patients is one of the most common endocrine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::01eb85d3cd9d8bc5dcf442ad05767fe7
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3122761
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3122761
Changes in thyroid function and thyroid function tests occur in patients with β-thalassemia major (TM). The frequency of hypothyroidism in TM patients ranges from 4% to 29 % in different reports. The wide variation has been attributed to several fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::c9d3f89984b350e02add9dfdcb30ed9e
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3106560
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3106560
PubMedID: 30657116 In adult thalassemia major (TM) patients, a number of occult and emerging endocrine complications, such as: central hypothyroidism (CH), thyroid cancer, latent hypocortisolism, and growth hormone deficiency (GHD) have emerged and b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______9491::0c1be4ab1f5dd71dc3c1d91c754bce1c
https://hdl.handle.net/20.500.12605/10872
https://hdl.handle.net/20.500.12605/10872
In adult thalassemia major (TM) patients, a number of occult and emerging endocrine complications, such as: central hypothyroidism (CH), thyroid cancer, latent hypocortisolism, and growth hormone deficiency (GHD) have emerged and been reported. As th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::73025d79b81cb943db4c14ebd9d54a32
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3123726
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3123726
Background: Haemoglobinopathies constitute the commonest recessive monogenic disorders worldwide, and the treatment of affected individuals presents a substantial global disease burden. β -thalassaemia is characterised by the reduced synthesis (β+)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::a9d09f3edacb26592116b4652a535c36
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3109190
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3109190
Autor:
De Sanctis, V. Soliman, A.T. Elsedfy, H. Di Maio, S. Canatan, D. Soliman, N. Karimi, M. Kattamis, C.
Introduction: Hypogonadism is the most frequently reported endocrine complication, affecting 40%–80% of thalassemia major (TM) patients. The prevalence and severity of hypogonadism in TM varies among studies, depending on patients’ age, genotype,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::e940d625bdfa891d2ee162540717c1c0
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3125586
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3125586
Background: Multi-transfused thalassemia major (TM) patients frequently develop severe endocrine complications, mainly due to iron overload, anemia, and chronic liver disease, which require prompt diagnosis, treatment and follow-up by specialists. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::61e8cf06bd90797ac0ff9fbbbb9db2ff
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3109222
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3109222